FindTrial
Sign In

Study on standardization and effectiveness of endoscopic treatment for gastrointestinal early cancer

Study on standardization and effectiveness of endoscopic treatment for gastrointestinal early cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17014133
Enrollment
Unknown
Registered
2017-12-25
Start date
2017-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal early cancer

Interventions

3:Different submucoal injection
2:Fibrin sealant sprayed on the ulcer
3:Esophageal stricture prevention after endoscopic treatment

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. The patients underwent endoscopic diagnosis or treatment for gastrointestinal early cancer; 3. The patients or their guardian agree to participate in the trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients cannot undergo endoscopic examination; 2. The endoscopic examination and treatment are contraindicated; 3. The patients refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
Early diagnosis rate of gastrointestinal cancer;Cure resection rate;Recurrence rate;Rates of complications;Survival rate;—

Secondary

MeasureTime frame
effective rate;Successful rate;—

Countries

China

Contacts

Public ContactEnqiang Linghu

Chinese PLA General Hospital

linghuenqiang@vip.sina.com+86 13501233558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026